Jakavi 20mg (Ruxolitinib) 20mg

Jakavi 20mg (Ruxolitinib) is a prescription medication used for treating certain blood disorders. This oral tablet helps manage symptoms by targeting specific pathways in the body. Suitable for patients requiring immune modulation. Always consult a healthcare provider before use.

Strength

20mg

Pack Size

56's

Storage

Ambient

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Jakavi 20mg is primarily used to treat myelofibrosis and polycythemia vera, conditions affecting the bone marrow. It helps reduce symptoms like enlarged spleen, fatigue, and night sweats. The medication works by inhibiting specific enzymes involved in blood cell production. Patients often seek Jakavi for its role in symptom management.

Side Effects

Common effects of Jakavi 20mg include dizziness, headache, and mild nausea. Some users report fatigue or temporary changes in blood counts. These effects are typically mild and may lessen over time. Monitoring by a healthcare provider is recommended to assess individual responses.

Precautions & Warnings

Store Jakavi 20mg at room temperature away from moisture and heat. Keep the medication in its original packaging until ready to use. Avoid exposure to extreme temperatures or direct sunlight. Always handle with clean, dry hands to maintain tablet integrity.

Avoid Interactions

Jakavi 20mg may interact with strong CYP3A4 inhibitors or inducers, altering its effectiveness. Grapefruit products can also affect how the body processes the medication. Discuss all current medications with a healthcare provider to avoid potential interactions. Alcohol use may increase side effects like dizziness.

Frequently Asked Questions

Jakavi 20mg is used to treat myelofibrosis and polycythemia vera by targeting specific enzymes in the body.

Store Jakavi 20mg at room temperature in a dry place, away from direct sunlight and moisture.

Consult a healthcare provider before combining Jakavi with other drugs to avoid potential interactions.

Common side effects include dizziness, headache, and mild nausea, which may lessen over time.

Long-term safety depends on individual health conditions; regular monitoring by a healthcare provider is recommended.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.